Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 459

Similar articles for PubMed (Select 16339692)

1.

Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.

Grosse R, Lund U, Caruso V, Fischer R, Janka GE, Magnano C, Engelhardt R, Dürken M, Nielsen P.

Ann N Y Acad Sci. 2005;1054:429-32.

PMID:
16339692
2.

Liver iron concentrations and urinary hepcidin in beta-thalassemia.

Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E.

Haematologica. 2007 May;92(5):583-8.

3.

Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.

Koren A, Fink D, Admoni O, Tennenbaum-Rakover Y, Levin C.

Eur J Haematol. 2010 Jan 1;84(1):72-8. doi: 10.1111/j.1600-0609.2009.01342.x.

PMID:
19732137
4.

Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1.

al-Refaie FN, Wickens DG, Wonke B, Kontoghiorghes GJ, Hoffbrand AV.

Br J Haematol. 1992 Oct;82(2):431-6.

PMID:
1419825
5.

Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response.

Aydinok Y, Evans P, Manz CY, Porter JB.

Haematologica. 2012 Jun;97(6):835-41. doi: 10.3324/haematol.2011.056317. Epub 2011 Dec 16.

6.

The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation.

Breuer W, Ronson A, Slotki IN, Abramov A, Hershko C, Cabantchik ZI.

Blood. 2000 May 1;95(9):2975-82.

7.

Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy.

Porter JB, Abeysinghe RD, Marshall L, Hider RC, Singh S.

Blood. 1996 Jul 15;88(2):705-13.

8.

Non-transferrin-bound iron in long-term transfusion in children with congenital anemias.

Wang WC, Ahmed N, Hanna M.

J Pediatr. 1986 Apr;108(4):552-7.

PMID:
3083076
9.

High nontransferrin bound iron levels and heart disease in thalassemia major.

Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, Hershko C, Cappellini MD.

Am J Hematol. 2009 Jan;84(1):29-33. doi: 10.1002/ajh.21317.

PMID:
19006228
10.

Methods for noninvasive measurement of tissue iron in Cooley's anemia.

Sheth S, Tang H, Jensen JH, Altmann K, Prakash A, Printz BF, Hordof AJ, Tosti CL, Azabagic A, Swaminathan S, Brown TR, Olivieri NF, Brittenham GM.

Ann N Y Acad Sci. 2005;1054:358-72.

PMID:
16339684
11.
12.

Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients.

Ooi GC, Khong PL, Chan GC, Chan KN, Chan KL, Lam W, Ng I, Ha SY.

Br J Haematol. 2004 Feb;124(3):385-90.

PMID:
14717788
13.

Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.

Evans P, Kayyali R, Hider RC, Eccleston J, Porter JB.

Transl Res. 2010 Aug;156(2):55-67. doi: 10.1016/j.trsl.2010.05.002. Epub 2010 May 27.

14.
15.

A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.

Pakbaz Z, Fischer R, Treadwell M, Yamashita R, Fung EB, Calvelli L, Quirolo K, Foote D, Harmatz P, Vichinsky EP.

Ann N Y Acad Sci. 2005;1054:486-91.

PMID:
16339703
16.

Oxidative status and malondialdehyde in beta-thalassaemia patients.

Cighetti G, Duca L, Bortone L, Sala S, Nava I, Fiorelli G, Cappellini MD.

Eur J Clin Invest. 2002 Mar;32 Suppl 1:55-60.

PMID:
11886433
17.

Bleomycin-detectable iron assay for non-transferrin-bound iron in hematologic malignancies.

von Bonsdorff L, Lindeberg E, Sahlstedt L, Lehto J, Parkkinen J.

Clin Chem. 2002 Feb;48(2):307-14.

18.

Iron overload following red blood cell transfusion and its impact on disease severity.

Ozment CP, Turi JL.

Biochim Biophys Acta. 2009 Jul;1790(7):694-701. doi: 10.1016/j.bbagen.2008.09.010. Epub 2008 Oct 18. Review.

PMID:
18992790
19.

A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.

Moayedi B, Gharagozloo M, Esmaeil N, Maracy MR, Hoorfar H, Jalaeikar M.

Eur J Haematol. 2013 Mar;90(3):202-9. doi: 10.1111/ejh.12061. Epub 2013 Jan 20.

PMID:
23278124
20.

No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.

Ghoti H, Goitein O, Koren A, Levin C, Kushnir T, Rachmilewitz E, Konen E.

Eur J Haematol. 2010 Jan 1;84(1):59-63. doi: 10.1111/j.1600-0609.2009.01355.x. Epub 2009 Sep 29.

PMID:
19793250
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk